Precision proton blast tested against tough pancreatic tumors
NCT ID NCT03652428
Summary
This study aims to find the safest and most effective dose of two chemotherapy drugs when given alongside a targeted form of radiation called proton therapy for locally advanced pancreatic cancer. It will involve 24 participants whose cancer cannot be surgically removed. The goal is to control the tumor, shrink it, and see if it becomes operable, while carefully monitoring side effects and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MedStar Georgetown University Hospital
RECRUITINGWashington D.C., District of Columbia, 20007, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland Medical Center/Maryland Proton Treatment Center
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.